Similar to This
Share price falls: BioNTech experiences setback with cancer drug: The Mainz-based company BioNTech is increasingly focusing on the fight against cancer. However ...
manager-magazin.de/unternehmen/pharma/biontech-rueckschlag-bei-krebswirkstoff-trastuzumab-pamirtecan-in-phase-3-studie-a-6f06b0f2-f5d6-4a65-95bb-7252a1dd4c40
Share price falls: BioNTech experiences setback with cancer drug
BioNTech stock: Surprising cancellation - | new details: BioNTech closes its Tübingen mRNA plant despite a multi-million euro offer. Why the talks ultimately ...
deraktionaer.de/artikel/deraktionaerplus/biontech-aktie-ueberraschende-absage-neue-details--20417497.html
BioNTech stock: Surprising cancellation - | new details
Bernd Förtsch on BioNTech: Resignation is overdue: Shareholder Bernd Förtsch sharply criticizes the events at the Corona superstar.
deraktionaer.de/artikel/aktien/bernd-foertsch-ueber-biontech-ruecktritt-ist-ueberfaellig-20409989.html
Bernd Förtsch on BioNTech: Resignation is overdue
Moderna stock knows no bounds - | what's going on with BioNTech?: The stock has roughly tripled since the positive data was released.
deraktionaer.de/artikel/pharma-biotech/moderna-aktie-kennt-kein-halten-mehr-was-ist-mit-biontech-los-20409301.html
Moderna stock knows no bounds - | what's going on with BioNTech?
mRNA cancer vaccine: After soaring high, setback for Mainz-based BioNTech: After strong test data from its US competitor Moderna, BioNTech's stock price shot ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/mrna-krebsimpfstoff-nach-hoehenflug-rueckschlag-fuer-biontech-6171151
mRNA cancer vaccine: After soaring high, setback for Mainz-based BioNTech
BioNTech: Cancer study halted - | Share price drops by double digits: BioNTech has halted a Phase II trial of an mRNA colon cancer vaccine, causing its share ...
deraktionaer.de/artikel/pharma-biotech/biontech-krebsstudie-gestoppt-aktie-knickt-zweistellig-ein-20407727.html
BioNTech: Cancer study halted - | Share price drops by double digits
BioNTech Competitor: Moderna Shares Soar After Melanoma Study: U.S. biotech company Moderna reports positive results in a study on the treatment of melanoma ...
manager-magazin.de/unternehmen/moderna-aktien-mit-kursrallye-melanom-studie-zeigt-erste-erfolge-bei-krebstherapie-auch-biontech-profitiert-a-d206673a-4bb5-4aa6-9ce3-6a926ffb5f00
BioNTech Competitor: Moderna Shares Soar After Melanoma Study
Forecast lowered: Vaccine stockpiles full in Germany, BioNTech deep in the red: Weak demand for the Covid-19 vaccine has resulted in significant losses and a ...
manager-magazin.de/unternehmen/pharma/biontech-umsatzprognose-gesenkt-wegen-voller-impfstofflager-a-f3f45a40-8696-4407-8f52-03a4cf7a3981
Forecast lowered: Vaccine stockpiles full in Germany, BioNTech deep in the ...
Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID shots: A Belgian court on Wednesday ordered ​Poland and Romania to take delivery of 1 ...
reuters.com/business/healthcare-pharmaceuticals/belgian-court-orders-poland-romania-buy-22-billion-pfizer-covid-vaccines-2026-04-01/
Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID ...
BioNTech sues Moderna - | the details: BioNTech sues Moderna for patent infringement; shares of both companies remain stable.
deraktionaer.de/artikel/pharma-biotech/biontech-verklagt-moderna-die-details-20395822.html
BioNTech sues Moderna - | the details
Moderna shares jump again, BioNTech also gains momentum - | what's going on?: Moderna shares rise. BioNTech also performs strongly. The reasons.
deraktionaer.de/artikel/deraktionaerplus/moderna-erneut-mit-kurssprung-auch-biontech-gibt-gas-was-ist-da-los-20394000.html
Moderna shares jump again, BioNTech also gains momentum - | what's ...
BioNTech rival with mega share price jump: Is the vaccine race starting all over again?
boerse-online.de/nachrichten/aktien/biontech-rivale-mit-mega-kurssprung-beginnt-das-impfstoff-rennen-von-vorne-20393447.html
BioNTech rival with mega share price jump: Is the vaccine race starting ...
Patents: Corona vaccines - | Bayer sues BioNTech, Pfizer and Moderna: Bayer accuses several manufacturers of copying an old technology to produce mRNA vaccines ...
handelsblatt.com/unternehmen/industrie/patente-corona-impfstoffe-bayer-verklagt-biontech-pfizer-und-moderna/100189227.html
Patents: Corona vaccines - | Bayer sues BioNTech, Pfizer and Moderna
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths: Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a ...
investors.com/news/technology/moderna-biontech-covid-vaccines-deaths-myocarditis/
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths
Biontech: Another high award for Sahin and Türeci: The award they received is a prestigious, but not a medical, honor. For this reason, the work of the two ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-weitere-hohe-auszeichnung-fuer-sahin-und-tuereci-4703531
Biontech: Another high award for Sahin and Türeci